Posted by Michael Wonder on 29 Sep 2023
Appili Therapeutics announces US FDA approval of Likmez (ATI-1501) metronidazole oral suspension
25 September 2023 - Currently Likmez is the only liquid oral suspension of metronidazole approved in the US.
Appili Therapeutics today announced that its manufacturing and commercialisation partner, Saptalis Pharmaceuticals received approval from the US FDA for metronidazole oral suspension 500 mg/5 mL (ATI-1501).
